Document is current
Any future updates will be listed below
-
Authors
Anchouche, Khalil
Thanassoulis, George
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research
Heart and Stroke Foundation of Canada
- License Information
-
More Information
Article History
Accepted: 4 October 2024
First Online: 22 November 2024
Declarations
:
: No animal or human subjects were used by the authors in this study.
: Dr. Thanassoulis has received consulting fees from Ionis Pharmaceuticals; and has participated in advisory boards for Amgen, Sanofi, Novartis, HLS Therapeutics, New Amsterdam, Novo Nordisk and Silence. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
